Anticorps Monoclonal anti-m6A

m6A Monoclonal Antibody for IHC, RIP, Dot Blot, ELISA, Indirect ELISA

Hôte / Isotype

Mouse / IgG3

Réactivité testée

m6A

Applications

IHC, RIP, Dot Blot, ELISA, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1D5E10

N° de cat : 68055-1-PBS

Synonymes

6-N-Methyladenoside, N6-methyladenosine



Informations sur le produit

68055-1-PBS cible m6A dans les applications de IHC, RIP, Dot Blot, ELISA, Indirect ELISA et montre une réactivité avec des échantillons m6A

Réactivité m6A
Hôte / Isotype Mouse / IgG3
Clonalité Monoclonal
Type Anticorps
Immunogène Peptide
Nom complet m6A
Numéro d’acquisition GenBankm6A
Symbole du gène
Identification du gène (NCBI)
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

m6A (N6-methyladenosine) is the most abundant internal modification in mammalian mRNA. This modification is installed by the m6A methyltransferases or termed "writers"such as METTL3 and METTL14, and can be reversed by demethylases that serve as "erasers" such as FTO and ALKBH5. The stability of m6A-modified mRNA is regulated by m6A reader protein YTHDFs, which recognizes m6A and reduces the stability of target transcripts. m6A modification and its regulatory proteins play critical roles in cancer pathogenesis and progression. m6A modification is also invovled in viruses life cycles, suggesting that drugs targets to m6A pathway could be used for antiviral thereapy.

Protocol for Dot Blot:
https://www.ptglab.com/protocol/68055-1-IgDotBlot.pdf

{{ptg:RelatedPrimaryAntibodies}}